These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 23415374)

  • 41. [Aberrant promoter hypermethylation of CHFR in nasopharyngeal carcinoma].
    Huang T; Du C; Yu N; Xiao X; Zhou X; Wang S; Huang G; Zhang Z
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Aug; 25(16):746-50. PubMed ID: 22070084
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic alterations in lung adenocarcinoma with a micropapillary component.
    Furukawa M; Toyooka S; Ichimura K; Yamamoto H; Soh J; Hashida S; Ouchida M; Shien K; Asano H; Tsukuda K; Miyoshi S
    Mol Clin Oncol; 2016 Feb; 4(2):195-200. PubMed ID: 26893860
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CHFR promoter hypermethylation and reduced CHFR mRNA expression in ovarian cancer.
    Gao Y; Lou G; Zhang GM; Sun XW; Ma YY; Yang YM; Liu G
    Int J Biol Markers; 2009; 24(2):83-9. PubMed ID: 19634111
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Checkpoint with forkhead-associated and ring finger promoter hypermethylation correlates with microsatellite instability in gastric cancer.
    Oki E; Zhao Y; Yoshida R; Masuda T; Ando K; Sugiyama M; Tokunaga E; Morita M; Kakeji Y; Maehara Y
    World J Gastroenterol; 2009 May; 15(20):2520-5. PubMed ID: 19469003
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The expression of
    Jia X; Qian R; Zhang B; Zhao S
    J Thorac Dis; 2016 Oct; 8(10):2682-2688. PubMed ID: 27867542
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pathobiologic implications of methylation and expression status of Runx3 and CHFR genes in gastric cancer.
    Hu SL; Huang DB; Sun YB; Wu L; Xu WP; Yin S; Chen J; Jiang XD; Shen G
    Med Oncol; 2011 Jun; 28(2):447-54. PubMed ID: 20300977
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CHFR methylation strongly correlates with methylation of DNA damage repair and apoptotic pathway genes in non-small cell lung cancer.
    Guo M; Alumkal J; Drachova T; Gao D; Marina SS; Jen J; Herman JG
    Discov Med; 2015 Mar; 19(104):151-8. PubMed ID: 25828518
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mechanism and pathobiologic implications of CHFR promoter methylation in gastric carcinoma.
    Gao YJ; Xin Y; Zhang JJ; Zhou J
    World J Gastroenterol; 2008 Aug; 14(32):5000-7. PubMed ID: 18763281
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular profiling of small cell lung cancer in a Japanese cohort.
    Wakuda K; Kenmotsu H; Serizawa M; Koh Y; Isaka M; Takahashi S; Ono A; Taira T; Naito T; Murakami H; Mori K; Endo M; Nakajima T; Ohde Y; Takahashi T; Yamamoto N
    Lung Cancer; 2014 May; 84(2):139-44. PubMed ID: 24657128
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CHFR suppression by hypermethylation sensitizes endometrial cancer cells to paclitaxel.
    Wang X; Yang Y; Xu C; Xiao L; Shen H; Zhang X; Li T; Li X
    Int J Gynecol Cancer; 2011 Aug; 21(6):996-1003. PubMed ID: 21792009
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chfr expression is downregulated by CpG island hypermethylation in esophageal cancer.
    Shibata Y; Haruki N; Kuwabara Y; Ishiguro H; Shinoda N; Sato A; Kimura M; Koyama H; Toyama T; Nishiwaki T; Kudo J; Terashita Y; Konishi S; Sugiura H; Fujii Y
    Carcinogenesis; 2002 Oct; 23(10):1695-9. PubMed ID: 12376479
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inactivating mutations and hypermethylation of the NKX2-1/TTF-1 gene in non-terminal respiratory unit-type lung adenocarcinomas.
    Matsubara D; Soda M; Yoshimoto T; Amano Y; Sakuma Y; Yamato A; Ueno T; Kojima S; Shibano T; Hosono Y; Kawazu M; Yamashita Y; Endo S; Hagiwara K; Fukayama M; Takahashi T; Mano H; Niki T
    Cancer Sci; 2017 Sep; 108(9):1888-1896. PubMed ID: 28677170
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Promoter hypermethylation of the Chfr gene in neoplastic and non-neoplastic gastric epithelia.
    Honda T; Tamura G; Waki T; Kawata S; Nishizuka S; Motoyama T
    Br J Cancer; 2004 May; 90(10):2013-6. PubMed ID: 15138487
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Frequent hypermethylation of the 5' CpG island of the mitotic stress checkpoint gene Chfr in colorectal and non-small cell lung cancer.
    Corn PG; Summers MK; Fogt F; Virmani AK; Gazdar AF; Halazonetis TD; El-Deiry WS
    Carcinogenesis; 2003 Jan; 24(1):47-51. PubMed ID: 12538348
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of CHFR promoter methylation with disease recurrence in locally advanced colon cancer.
    Tanaka M; Chang P; Li Y; Li D; Overman M; Maru DM; Sethi S; Phillips J; Bland GL; Abbruzzese JL; Eng C
    Clin Cancer Res; 2011 Jul; 17(13):4531-40. PubMed ID: 21551253
    [TBL] [Abstract][Full Text] [Related]  

  • 56. DNA hypermethylation of the ZNF132 gene participates in the clinicopathological aggressiveness of 'pan-negative'-type lung adenocarcinomas.
    Hamada K; Tian Y; Fujimoto M; Takahashi Y; Kohno T; Tsuta K; Watanabe SI; Yoshida T; Asamura H; Kanai Y; Arai E
    Carcinogenesis; 2021 Feb; 42(2):169-179. PubMed ID: 33152763
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CHFR protein expression predicts outcomes to taxane-based first line therapy in metastatic NSCLC.
    Pillai RN; Brodie SA; Sica GL; Shaojin Y; Li G; Nickleach DC; Yuan L; Varma VA; Bonta D; Herman JG; Brock MV; Ribeiro MJ; Ramalingam SS; Owonikoko TK; Khuri FR; Brandes JC
    Clin Cancer Res; 2013 Mar; 19(6):1603-11. PubMed ID: 23386692
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aberrant gene methylation in the peritoneal fluid is a risk factor predicting peritoneal recurrence in gastric cancer.
    Hiraki M; Kitajima Y; Sato S; Nakamura J; Hashiguchi K; Noshiro H; Miyazaki K
    World J Gastroenterol; 2010 Jan; 16(3):330-8. PubMed ID: 20082478
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The ACIN1 gene is hypermethylated in early stage lung adenocarcinoma.
    Shu Y; Iijima T; Sun W; Kano J; Ishiyama T; Okubo C; Anami Y; Tanaka R; Fukai S; Noguchi M
    J Thorac Oncol; 2006 Feb; 1(2):160-7. PubMed ID: 17409846
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aberrant methylation of SPARC in human lung cancers.
    Suzuki M; Hao C; Takahashi T; Shigematsu H; Shivapurkar N; Sathyanarayana UG; Iizasa T; Fujisawa T; Hiroshima K; Gazdar AF
    Br J Cancer; 2005 Mar; 92(5):942-8. PubMed ID: 15756262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.